News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

FDA Approves Chelsea Therapeutics’ Northera for Treatment of Neurogenic Orthostatic Hypotension


(February 19, 2014) - The U.S. Food and Drug Administration today approved Northera capsules (droxidopa) for the treatment of neurogenic orthostatic hypotension (NOH). NOH is a rare, chronic and often debilitating drop in blood pressure upon standing that is associated with Parkinson's disease, multiple-system atrophy, and pure autonomic failure.  Read more…